Table of Content

1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Personalized Medicine Market



6. Market Share
6.1 Product
6.2 Application
6.3 End Users
6.4 Country


7. Product
7.1 Personalized Medicine Therapeutics
7.2 Personalized Medicine Diagnostics
7.3 Personalized Medical Care
7.4 Personalized Nutrition and Wellness


8. Application
8.1 Oncology
8.2 Infectious disease
8.3 Neurology or Psychiatry
8.4 Cardiovascular
8.5 Others


9. End Users
9.1 Hospitals
9.2 Diagnostic Centers
9.3 Research & Academic Institutes
9.4 Others


10. Country
10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Company Analysis
13.1 Abbott Laboratories

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 GE Healthcare,Inc

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue

13.3 Aadi Bioscience, Inc.

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue

13.4 Illumina, Inc.

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue

13.5 QIAGEN

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue

13.6 Eli Lilly and Company

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue

13.7 Takeda Pharmaceutical Company Ltd

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue

13.8 AbbVie Inc

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue

13.9 F. Hoffmann-La Roche Ltd.

13.9.1 Overview
13.9.2 Recent Development
13.9.3 Revenue



List of Figures

0

List of Tables

0